XML 406 R75.htm IDEA: XBRL DOCUMENT v3.21.1
Investments in Associates - Gelesis (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Disclosure of associates [Line Items]        
Non-current assets $ 575,645 $ 772,333    
Current assets 414,348 168,845    
Non-current liabilities 155,531 151,579    
Current liabilities 180,924 139,201    
Share of associate loss allocated to long-term interest 23,006      
Investments in associates 0 10,642 $ 0 $ 0
Revenue 11,768 9,807 20,748  
Total comprehensive income/(loss) for the year $ 5,037 $ 366,055 $ (70,899)  
Gelesis [Member]        
Disclosure of associates [Line Items]        
Proportion of ownership interest in associate 47.90% 49.30%    
Non-current assets $ 372,184 $ 369,336    
Current assets 92,875 40,079    
Non-current liabilities (133,743) (82,406)    
Current liabilities (300,748) (216,852)    
Non controlling interests and options issued to third parties (6,577) (1,542)    
Net assets attributable to shareholders 23,989 108,615    
Group's share of net assets 11,481 53,580    
Goodwill 8,216 0    
Impairment of investment (42,702) (42,938)    
Share of associate loss allocated to long-term interest 23,006 0    
Investments in associates 0 10,642    
Revenue 21,442 0    
Income/(loss) from continuing operations (100%) (71,157) 74,573    
Total comprehensive income/(loss) for the year (70,178) 74,573    
Group's share in income/(loss) from continuing operations (34,117) 37,136    
Group's share of total comprehensive income/(loss) $ (33,648) $ 37,136